Harvard-Affiliated Director, Oncologic Emergencies Research

Sitcancer; Boston (MA); Híbrido; USD 210.000 - 400.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Competitive compensation

Research infrastructure support

Start-up package

Harvard faculty appointment

Descripción de la vacante

Beth Israel Deaconess Medical Center in Boston, MA invites applications for Director of Oncologic Emergencies Research within the Department of Emergency Medicine. This academic physician-leadership role will build a national research program focused on cancer patients presenting to the ED with acute illness, including immunotherapy toxicities and treatment-related adverse events.

The appointee will lead collaborations across oncology and critical care, develop clinical pathways, pursue

Formación

• MD or equivalent medical degree.
• Board certification (or eligibility) in Emergency Medicine.
• Commitment to clinical, translational, basic science, or public health research.
• Strong interpersonal and communication skills with a collaborative spirit.
• Eligibility for Massachusetts medical licensure.

Responsabilidades

• Execute a productive research program in oncologic emergencies evidenced by publications and extramural funding.
• Collaborate with oncologists and other specialists to advance research in the field.
• Contribute to the department’s academic and strategic goals through clinical service, scholarly engagement, and leadership.

Conocimientos

Interpersonal skills

Collaborative mindset

Educación

MD or equivalent medical degree

Board certification (or eligibility) in Emergency Medicine

Massachusetts medical licensure eligibility

Descripción del empleo

Beth Israel Deaconess Medical Center in Boston, MA invites applications for Director of Oncologic Emergencies Research within the Department of Emergency Medicine. This academic physician-leadership role will build a national research program focused on cancer patients presenting to the ED with acute illness, including immunotherapy toxicities and treatment-related adverse events.

The appointee will lead collaborations across oncology and critical care, develop clinical pathways, pursue